drugset
drugset / Trial / NCT02332044

Drug Interaction Study Between Erdosteine and Bepotastine Besilate in Healthy Adult Volunteers

NCT02332044 ↗

Phase 1 Completed 36 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to evaluate the drug-drug interaction between Erdosteine and Bepotastine besilate in healthy adult volunteers.

Timeline

Start
2014-04
Primary completion
2014-09
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Bepotastine Small molecule 10 mg Oral
Subject Erdosteine Small molecule 300 mg Oral

Indications

No indication recorded.